Concordia International Corp (CXR) Insider Alternative Asset Manage Solus Purchases 400 Shares

Concordia International Corp (TSE:CXR) (NASDAQ:CXRX) insider Alternative Asset Manage Solus acquired 400 shares of Concordia International stock in a transaction that occurred on Friday, November 2nd. The shares were purchased at an average price of C$26.09 per share, with a total value of C$10,436.00.

Alternative Asset Manage Solus also recently made the following trade(s):

  • On Friday, October 26th, Alternative Asset Manage Solus acquired 2,000 shares of Concordia International stock. The shares were purchased at an average price of C$27.04 per share, with a total value of C$54,080.00.
  • On Monday, October 29th, Alternative Asset Manage Solus acquired 5,000 shares of Concordia International stock. The shares were purchased at an average price of C$27.15 per share, with a total value of C$135,750.00.
  • On Friday, October 19th, Alternative Asset Manage Solus acquired 10,200 shares of Concordia International stock. The shares were purchased at an average price of C$25.05 per share, with a total value of C$255,510.00.
  • On Thursday, October 4th, Alternative Asset Manage Solus sold 6,500 shares of Concordia International stock. The shares were sold at an average price of C$27.35, for a total value of C$177,775.00.
  • On Thursday, September 27th, Alternative Asset Manage Solus acquired 3,000 shares of Concordia International stock. The shares were purchased at an average price of C$23.97 per share, with a total value of C$71,910.00.
  • On Monday, October 1st, Alternative Asset Manage Solus acquired 17,100 shares of Concordia International stock. The shares were purchased at an average price of C$24.50 per share, with a total value of C$418,950.00.
  • On Monday, September 17th, Alternative Asset Manage Solus sold 1,100 shares of Concordia International stock. The shares were sold at an average price of C$26.00, for a total value of C$28,600.00.
  • On Thursday, September 13th, Alternative Asset Manage Solus sold 1,000 shares of Concordia International stock. The shares were sold at an average price of C$26.06, for a total value of C$26,060.00.

CXR traded up C$0.16 during midday trading on Thursday, reaching C$27.38. The company had a trading volume of 2,400 shares, compared to its average volume of 3,474. Concordia International Corp has a 1 year low of C$19.02 and a 1 year high of C$417.00.

Concordia International (TSE:CXR) (NASDAQ:CXRX) last issued its quarterly earnings results on Wednesday, August 8th. The company reported C($175.76) EPS for the quarter, missing analysts’ consensus estimates of C($27.27) by C($148.49). The business had revenue of C$180.02 million during the quarter.

Separately, Bloom Burton restated a “hold” rating on shares of Concordia International in a research report on Tuesday, September 11th.

WARNING: “Concordia International Corp (CXR) Insider Alternative Asset Manage Solus Purchases 400 Shares” was published by WKRB News and is owned by of WKRB News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.wkrb13.com/2018/11/08/concordia-international-corp-cxr-insider-alternative-asset-manage-solus-purchases-400-shares.html.

About Concordia International

Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.

See Also: What are the Benefits of Index Funds?

Insider Buying and Selling by Quarter for Concordia International (TSE:CXR)

Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply